Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

Neuromuscular Disorders

Volumn 18, Issue 1, 2008, Pages 19-26

  Solari, A ^a   Laura M ^a   Salsano, E ^a   Radice, D ^b   Pareyson, D ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Charcot Marie Tooth disease; Outcome measures; Randomised clinical trial; Reliability

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DYNAMOMETER; ELBOW FLEXION; FEMALE; FOOT; HAND GRIP; HAND MOVEMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IMMOBILIZATION; INTERRATER RELIABILITY; INTRARATER RELIABILITY; KNEE; LEG MOVEMENT; MALE; MUSCLE ISOMETRIC CONTRACTION; OUTCOME ASSESSMENT; PINCH STRENGTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RATING SCALE; RELIABILITY;

EID: 38649125200     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2007.09.006     Document Type: Article

References (25)

1. Martyn C.N., and Hughes R.A.C. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 62 (1997) 310-318
2. Pareyson D., Scaioli V., and Laurà M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromol Med 8 (2006) 3-22
3. Passage E., Norreel J.C., Noack-Fraissignes P., et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 10 (2004) 396-401
4. Huxley C., Passage E., Manson A., et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5 (1996) 563-569
5. Shy M.E., Blake J., Krajewski K., et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64 (2005) 1209-1214
6. Pareyson D., Schenone A., Fabrizi G.M., et al. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol (EudraCT no:2006-000032-27). Pharmacol Res 54 (2006) 436-441
7. Reilly MM, de Jonghe P, Pareyson D. 136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A). 8-10 April 2005, Naarden, The Netherlands. Neuromuscul Disord 2006;16:396-402.
8. Graham R.C., and Hughes R.A.C. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77 (2006) 973-976
9. Merkies I.S., Schmitz P.I., van der Meche F.G., and van Doorn P.A. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 54 (2000) 943-949
10. Solari A., Radice D., Manneschi L., Motti L., and Montanari E. The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci 228 (2005) 71-74
11. Goodkin D.E., Hertsgaard D., and Seminary J. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehab 69 (1988) 850-854
12. Merlini L., Mazzone E., Solari A., and Morandi L. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve 26 (2002) 64-70
13. Merlini L., Solari A., Vita G., et al. Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study. J Child Neurol 18 (2003) 537-541
14. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
15. Guyatt G., Walter S., and Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 40 (1987) 171-178
16. Shrout P.E., and Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86 (1979) 420-428
17. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-317
18. Svensson E., and Häger-Ross C. Hand function in Charcot-Marie-Tooth: test-retest reliability of some measurements. Clin Rehab 20 (2006) 896-908
19. Kilmer D.D., McCrory M.A., Wright N.C., Rosko R.A., Kim H.R., and Aitkens S.G. Hand-held dynamometry reliability in persons with neuropathic weakness. Arch Phys Med Rehab 78 (1997) 1364-1368
20. Selles R.W., van Ginneken B.T., Schreuders T.A., Janssen W.G., and Stam H.J. Dynamometry of intrinsic hand muscles in patients with Charcot-Marie-Tooth disease. Neurology 67 (2006) 2022-2027
21. Hughes R., Bensa S., Willison H., et al., Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50 (2001) 195-201
22. Merkies I.S., Schmitz P.I., van der Meché F.G., Samijn J.P., van Doorn P.A., and for the Inflammatory Neuropathy Cause and Treatment (INCAT) group. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72 (2002) 596-601
23. McMahon L.M., Burdett L.C., and Whithey S.L. Effects of muscle groups and placement site in reliability of hand-held dynamometry strength measurements. J Ortop Sports Phys Ther 15 (1992) 236-241
24. Philips B.A., Lo S.K., and Mastaglia F.L. Muscle force measured using "break" testing with a hand-held myometer in normal subjects aged 20 to 69 years. Arch Phys Med Rehab 81 (2000) 653-661
25. van der Ploeg R.J., Fidler V., and Oosterhuis H.J. Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 54 (1991) 244-247